CA3173030C - Extraction d'alcaloide psychoactif principalement phosphoryle au moyen d'alcali - Google Patents
Extraction d'alcaloide psychoactif principalement phosphoryle au moyen d'alcali Download PDFInfo
- Publication number
- CA3173030C CA3173030C CA3173030A CA3173030A CA3173030C CA 3173030 C CA3173030 C CA 3173030C CA 3173030 A CA3173030 A CA 3173030A CA 3173030 A CA3173030 A CA 3173030A CA 3173030 C CA3173030 C CA 3173030C
- Authority
- CA
- Canada
- Prior art keywords
- psychoactive
- alkaloid
- solvent
- weight
- psychoactive alkaloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/078—Psilocybe
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0215—Solid material in other stationary receptacles
- B01D11/0253—Fluidised bed of solid materials
- B01D11/0257—Fluidised bed of solid materials using mixing mechanisms, e.g. stirrers, jets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
- B01D11/0284—Multistage extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0292—Treatment of the solvent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Linvention concerne lextraction de composés psychoactifs dorganismes destinés à être utilisés en médecine. L'extraction est réalisée avec un acide fort ou une base forte pour favoriser ou inhiber la déphosphorylation. L'extrait sous forme de suspension est standardisé avec un excipient ajouté de telle sorte que, lorsqu'elle est séchée, la composition en poudre a une concentration en alcaloïde psychoactif totale spécifiée avec un rapport connu de phosphorylé en alcaloïdes psychoactifs déphosphorylés.
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040317P | 2020-06-17 | 2020-06-17 | |
| US63/040,317 | 2020-06-17 | ||
| US202063046089P | 2020-06-30 | 2020-06-30 | |
| US63/046,089 | 2020-06-30 | ||
| CA3088384A CA3088384C (fr) | 2020-06-17 | 2020-07-29 | Extraction de composes psychoactifs de champignons psilocybines |
| CA3089455A CA3089455C (fr) | 2020-06-17 | 2020-08-07 | Extraction au methanol de composes psychoactifs de champignons |
| CA3089455 | 2020-08-07 | ||
| CA3088384 | 2020-09-27 | ||
| CA3097246A CA3097246C (fr) | 2020-10-23 | 2020-10-23 | Processus d`obtention d`une solution alcaloide psychoactive purifiee |
| CA3097246 | 2020-10-23 | ||
| CA3101765A CA3101765A1 (fr) | 2020-12-04 | 2020-12-04 | Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee |
| CA3101765 | 2020-12-04 | ||
| CA3103707A CA3103707C (fr) | 2020-12-18 | 2020-12-18 | Composition normalisee d'extrait d'alcaloide psychoactif |
| CA3103707 | 2020-12-18 | ||
| CA3169140A CA3169140C (fr) | 2020-06-17 | 2021-06-14 | Extraction d'alcaloides psychoactifs capables de phosphorylation a dephosphorylation controlee |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3169140A Division CA3169140C (fr) | 2020-06-17 | 2021-06-14 | Extraction d'alcaloides psychoactifs capables de phosphorylation a dephosphorylation controlee |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3173030A1 CA3173030A1 (fr) | 2021-12-17 |
| CA3173030C true CA3173030C (fr) | 2024-05-14 |
Family
ID=79268788
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3173030A Active CA3173030C (fr) | 2020-06-17 | 2021-06-14 | Extraction d'alcaloide psychoactif principalement phosphoryle au moyen d'alcali |
| CA3169140A Active CA3169140C (fr) | 2020-06-17 | 2021-06-14 | Extraction d'alcaloides psychoactifs capables de phosphorylation a dephosphorylation controlee |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3169140A Active CA3169140C (fr) | 2020-06-17 | 2021-06-14 | Extraction d'alcaloides psychoactifs capables de phosphorylation a dephosphorylation controlee |
Country Status (2)
| Country | Link |
|---|---|
| CA (2) | CA3173030C (fr) |
| WO (1) | WO2021253116A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220092509A (ko) | 2019-10-01 | 2022-07-01 | 엠피리언 뉴로사이언스, 인크. | 트립타민 발현을 조절하는 균류의 유전자 공학 |
| US20240050502A1 (en) * | 2020-12-16 | 2024-02-15 | Caamtech, Inc. | Amanita muscaria compounds |
| EP4155306A1 (fr) | 2021-01-15 | 2023-03-29 | Beckley Psytech Limited | Analogue neuroactif d'ergoline |
| US20220370413A1 (en) | 2021-03-06 | 2022-11-24 | Mind Medicine, Inc. | Formulations of psilocin that have enhanced stability |
| WO2023130076A2 (fr) | 2021-12-31 | 2023-07-06 | Empyrean Neuroscience, Inc. | Cibles et voies pour la production de composés alcaloïdes |
| EP4486448A1 (fr) | 2022-03-04 | 2025-01-08 | Reset Pharmaceuticals, Inc. | Co-cristaux ou sels comprenant de la psilocine |
| US12264131B2 (en) | 2022-08-19 | 2025-04-01 | Beckley Psytech Limited | Pharmaceutically acceptable salts and compositions thereof |
| US12246005B2 (en) | 2023-06-13 | 2025-03-11 | Beckley Psytech Limited | 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations |
| GB202313750D0 (en) * | 2023-09-08 | 2023-10-25 | Psyence Group Inc | A process for obtaining a purified psychoactive alkaloid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU36879A1 (fr) | 1958-02-21 |
-
2021
- 2021-06-14 WO PCT/CA2021/050813 patent/WO2021253116A1/fr not_active Ceased
- 2021-06-14 CA CA3173030A patent/CA3173030C/fr active Active
- 2021-06-14 CA CA3169140A patent/CA3169140C/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3169140C (fr) | 2024-10-22 |
| WO2021253116A1 (fr) | 2021-12-23 |
| CA3173030A1 (fr) | 2021-12-17 |
| CA3169140A1 (fr) | 2021-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3173030C (fr) | Extraction d'alcaloide psychoactif principalement phosphoryle au moyen d'alcali | |
| AU2023285751B2 (en) | Powdered Composition Containing a Mushroom Extract Comprising a Psychoactive Alkaloid | |
| US11382942B2 (en) | Extraction of psychoactive compounds from psilocybin fungus | |
| US11510952B2 (en) | Ethanol extraction of psychoactive compounds from psilocybin fungus | |
| CA3137016C (fr) | Extraction d'alcaloide psychoactif et composition avec dephosphorylationattenuees |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |